Unitat de Lípids i Risc Vascular, Servei de Medicina Interna, Hospital Universitari de Bellvitge, Barcelona, Spain.
Clin Cardiol. 2010 Jul;33(7):418-23. doi: 10.1002/clc.20774.
Total and low-density lipoprotein cholesterol (LDL-C) concentrations in coronary artery disease have progressively declined, although high-density lipoprotein cholesterol (HDL-C) has not always been evaluated. The prevalence and related factors of low HDL-C in a cohort of Spanish patients with acute coronary syndromes (ACS) were assessed.
Clinical and laboratory data registered at admission and at discharge of 648 patients admitted to coronary care units of 6 Spanish hospitals for ACS between January 2004 and September 2007 were analyzed.
Low HDL-C (HDL-C < 1.04 mmol/L) was observed in 367 (56.6%) patients. Male gender, smoking, hypertension, diabetes, high body mass index, and triglycerides were related to low HDL-C. Female gender was the strongest protective factor against low HDL-C (0.619; 95% confidence interval [CI]: 0.410-0.934; P = 0.022), whereas high triglycerides (1.653; 95% CI: 1.323-2.064; P < 0.001) followed by previous ischemic disease (1.504; 95% CI: 1.073-2.110; P = 0.018) were the strongest factors associated with low HDL-C. One-third of patients were taking statins at admission, but only 2% were on fibrate therapy. A large increase in statin therapy, but not in other hypolipemiant drug therapy, between admission and discharge was noted in the whole cohort and among patients with low HDL-C.
Spanish patients with ACS have a very high prevalence of low HDL-C. Male gender, high triglycerides, and previous ischemic disease are strong, independent factors associated with this disorder. As low HDL-C remains almost completely untreated in ACS, strategies to enhance the treatment of this lipoprotein abnormality are urgently required.
尽管高密度脂蛋白胆固醇(HDL-C)并未始终得到评估,但在患有急性冠状动脉综合征(ACS)的西班牙患者队列中,冠状动脉疾病的总胆固醇和低密度脂蛋白胆固醇(LDL-C)浓度逐渐降低。
分析了 2004 年 1 月至 2007 年 9 月期间在西班牙 6 家医院的冠心病监护病房因 ACS 入院的 648 例患者的入院和出院时的临床和实验室数据。
367 例(56.6%)患者存在低 HDL-C(HDL-C<1.04mmol/L)。男性,吸烟,高血压,糖尿病,高体重指数和甘油三酯与低 HDL-C 有关。女性是低 HDL-C 的最强保护因素(0.619;95%置信区间[CI]:0.410-0.934;P=0.022),而高甘油三酯(1.653;95%CI:1.323-2.064;P<0.001)和既往缺血性疾病(1.504;95%CI:1.073-2.110;P=0.018)是与低 HDL-C 最相关的最强因素。入院时有三分之一的患者正在服用他汀类药物,但只有 2%的患者接受了贝特类药物治疗。在整个队列和低 HDL-C 患者中,入院和出院之间他汀类药物治疗的大量增加,但其他降脂药物治疗没有增加。
西班牙 ACS 患者低 HDL-C 的患病率非常高。男性,高甘油三酯和既往缺血性疾病是与该疾病相关的强独立因素。由于 ACS 中低 HDL-C 的治疗几乎完全未得到治疗,因此迫切需要采取策略来增强对这种脂蛋白异常的治疗。